Equity Profile

ZBH

Zimmer Biomet Holdings, Inc.

Health CareHealth Care Equipment$15.9B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Zimmer Biomet Holdings, Inc. is a leading company in the health care equipment sector, specializing in orthopedic products and solutions....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and overall financial health, which investors closely monitor.

Not available

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and meet customer demand, which is vital for long-term success.

Not available

Wall Street expectations, options signals, track record, and call prep available with Pro.

ZBH Q2-2026 Earnings Preview

Context

Company Snapshot

Zimmer Biomet Holdings, Inc. is a leading company in the health care equipment sector, specializing in orthopedic products and solutions. With a market cap of $16 billion, it plays a crucial role in improving patient outcomes through innovative medical technologies.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+2.87%

Avg Stock Reaction

-3.79%

Last Quarter Recap

In Q1-2026, Zimmer Biomet reported an EPS of $2.09, exceeding expectations by 12.55%. However, the stock dropped 10.57% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as there are no analyst estimates available, making it hard to gauge market sentiment ahead of the earnings report.

Bull Case

If Zimmer Biomet continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially driving the stock higher.

Bear Case

Conversely, any signs of declining revenue or increased competition could lead to negative sentiment, especially given the recent stock price volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's history of beating EPS estimates, this figure will be crucial for investor sentiment and stock performance.

How is revenue growth trending, especially in key product segments?

Revenue growth is essential for assessing the company's market position and future prospects, making it a focal point for investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Zimmer Biomet's potential for revenue growth in emerging markets, which could significantly boost overall performance.

Supporting Evidence

The company has a strong pipeline of new products that could drive sales.

Historical trends show that the company often beats EPS estimates, suggesting potential upside.

Options pricing indicates a larger expected move than historical averages, hinting at potential volatility.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the company's ability to maintain or exceed previous earnings while addressing any revenue concerns.

Bull Confirmed If

An EPS of $2.20 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $1.90 would support the bear case, suggesting potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±13.66%

Historical Avg

±7.7%

Pricing rich

The options market is pricing in a significant move of approximately 13.66%, indicating heightened uncertainty ahead of the earnings report.

Options are pricing ±13.7% while ZBH has averaged ±7.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.8%

Calls (12K)P/C Ratio: 0.43Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zimmer Biomet beats expectations, history suggests the stock could rise by around 5.15% on the first day, confirming strong operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.

Miss

A miss on earnings could lead to a decline of approximately 5.71%, as seen in past quarters, indicating investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management strategies and their effect on margins.
4Discussion of international market performance, particularly in emerging regions.
5Any guidance on future earnings expectations or strategic initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Zimmer Biomet Holdings, Inc. is a leading company in the health care equipment sector, specializing in orthopedic products and solutions....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and overall financial health, which investors closely monitor.

Not available

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and meet customer demand, which is vital for long-term success.

Not available

Wall Street expectations, options signals, track record, and call prep available with Pro.

ZBH Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+2.87%

Avg Stock Reaction

-3.79%

Last Quarter Recap

In Q1-2026, Zimmer Biomet reported an EPS of $2.09, exceeding expectations by 12.55%. However, the stock dropped 10.57% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as there are no analyst estimates available, making it hard to gauge market sentiment ahead of the earnings report.

Bull Case

If Zimmer Biomet continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially driving the stock higher.

Bear Case

Conversely, any signs of declining revenue or increased competition could lead to negative sentiment, especially given the recent stock price volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's history of beating EPS estimates, this figure will be crucial for investor sentiment and stock performance.

How is revenue growth trending, especially in key product segments?

Revenue growth is essential for assessing the company's market position and future prospects, making it a focal point for investors.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Zimmer Biomet's potential for revenue growth in emerging markets, which could significantly boost overall performance.

Supporting Evidence

The company has a strong pipeline of new products that could drive sales.

Historical trends show that the company often beats EPS estimates, suggesting potential upside.

Options pricing indicates a larger expected move than historical averages, hinting at potential volatility.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the company's ability to maintain or exceed previous earnings while addressing any revenue concerns.

Bull Confirmed If

An EPS of $2.20 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $1.90 would support the bear case, suggesting potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±13.66%

Historical Avg

±7.7%

Pricing rich

The options market is pricing in a significant move of approximately 13.66%, indicating heightened uncertainty ahead of the earnings report.

Options are pricing ±13.7% while ZBH has averaged ±7.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.8%

Calls (12K)P/C Ratio: 0.43Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zimmer Biomet beats expectations, history suggests the stock could rise by around 5.15% on the first day, confirming strong operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting cautious investor sentiment.

Miss

A miss on earnings could lead to a decline of approximately 5.71%, as seen in past quarters, indicating investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management strategies and their effect on margins.
4Discussion of international market performance, particularly in emerging regions.
5Any guidance on future earnings expectations or strategic initiatives.